These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 6781025)

  • 1. [Principles and concepts of teratogenesis. I. The teratogenic injury (author's transl)].
    Rooze M
    Rev Med Brux; 1980 Oct; 1(8):523-33. PubMed ID: 6781025
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lithium and pregnancy (author's transl)].
    Mignot G; Devic M; Dumont M
    J Gynecol Obstet Biol Reprod (Paris); 1978; 7(7):1303-17. PubMed ID: 106083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drugs, environment and teratogenesis].
    Mariani L
    Clin Ter; 1976 Apr; 77(1):3-19. PubMed ID: 827412
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs of abuse: teratogenic and mutagenic considerations.
    Evans MA; Stevens MW; Mantilla-Plata B; Harbison RD
    Addict Dis; 1975; 2(1-2):45-61. PubMed ID: 1163373
    [No Abstract]   [Full Text] [Related]  

  • 5. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of known environmental teratogens: drugs and chemicals.
    Beckman DA; Brent RL
    Clin Perinatol; 1986 Sep; 13(3):649-87. PubMed ID: 3533369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Embryotoxic properties of drugs].
    Smol'nikova NM; Golovanova IV; Proĭnova VA; Skosyreva AM; Strekalova SN
    Farmakol Toksikol; 1982; 45(4):115-9. PubMed ID: 6751867
    [No Abstract]   [Full Text] [Related]  

  • 9. [The teratogenic action of parbendazole].
    Mercier-Parot L
    Therapie; 1976; 31(4):491-503. PubMed ID: 1036798
    [No Abstract]   [Full Text] [Related]  

  • 10. Teratogenicity of sodium arsenate in rats.
    Beaudoin AR
    Teratology; 1974 Oct; 10(2):153-7. PubMed ID: 4428424
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics].
    Cahen R
    Eur J Toxicol Hyg Environ; 1972; Suppl 3():67-80. PubMed ID: 4157455
    [No Abstract]   [Full Text] [Related]  

  • 12. [Editorial: Teratogenic agents].
    Ferrier PE
    Helv Paediatr Acta; 1975 May; 30(1):5-9. PubMed ID: 1158766
    [No Abstract]   [Full Text] [Related]  

  • 13. [The basic methodological approaches to testing the teratogenic activity of chemical substances].
    Dyban AP; Baranov VS; Akimova IM
    Arkh Anat Gistol Embriol; 1970; 59(10):89-100. PubMed ID: 5511190
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacotherapy during pregnancy. Teratological aspects (author's transl)].
    Held KR
    MMW Munch Med Wochenschr; 1981 Aug; 123(32-33):1235-8. PubMed ID: 6790971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TERATOGENIC EFFECT OF A SULPHONAMIDE IN EXPERIMENTAL ANIMALS.
    PAGET GE; THORPE E
    Br J Pharmacol Chemother; 1964 Oct; 23(2):305-12. PubMed ID: 14228132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is fluphenazine a teratogen?
    Merlob P; Stahl B; Maltz E
    Am J Med Genet; 1994 Aug; 52(2):231-2. PubMed ID: 7802015
    [No Abstract]   [Full Text] [Related]  

  • 17. Corticosteroid teratogenicity.
    Rowland JM; Hendrickx AG
    Adv Vet Sci Comp Med; 1983; 27():99-128. PubMed ID: 6359839
    [No Abstract]   [Full Text] [Related]  

  • 18. [The superior celosomia (author's transl)].
    Gaillard D; Morville P; Birembaut P; Mourad H; Quereux C; Leroux B; Daoud S
    Ann Pediatr (Paris); 1981 Jan; 28(1):51-4. PubMed ID: 7235530
    [No Abstract]   [Full Text] [Related]  

  • 19. Problems associated with the screening of drugs for possible teratogenic activity.
    Palmer AK
    Exp Embryol Teratol; 1974; 1(0):16-33. PubMed ID: 4464051
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.